XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Consolidated Statements of Income [Abstract]      
Net sales $ 650,308,000 $ 540,782,000 $ 535,831,000
Cost of goods sold 532,443,000 431,321,000 417,431,000
Gross profit 117,865,000 109,461,000 118,400,000
Operating expenses:      
General and administrative 57,499,000 53,847,000 53,224,000
Sales and marketing 22,833,000 18,024,000 21,037,000
Research and development 10,502,000 8,563,000 9,200,000
Foreign exchange impact of lease liabilities and forward contracts (1,673,000) (17,606,000) 18,201,000
Total operating expenses 89,161,000 62,828,000 101,662,000
Operating income 28,704,000 46,633,000 16,738,000
Interest expense, net 15,555,000 15,770,000 25,039,000
Income (loss) before income tax expense (benefit) 13,149,000 30,863,000 (8,301,000)
Income tax expense (benefit) 5,788,000 9,387,000 (1,011,000)
Net income (loss) $ 7,361,000 $ 21,476,000 $ (7,290,000)
Basic net income (loss) per share (in dollar per share) $ 0.38 $ 1.13 $ (0.39)
Diluted net income (loss) per share (in dollar per share) $ 0.38 $ 1.11 $ (0.39)
Weighted average number of shares outstanding:      
Basic (in shares) 19,119,727 19,023,145 18,913,788
Diluted (in shares) 19,559,646 19,387,555 18,913,788